JOA - 2026-11-06 - Journal Article
Pericapsular Nerve Group Block Significantly Reduces Morphine Consumption and Improves Early Recovery Following Primary Total Hip Arthroplasty: A Randomized Double-Blind Sham-Controlled Trial.
Demirkıran F, Özdemir Kol İ, Altun O
Topics
Key Takeaway
Ultrasound-guided PENG block reduced 24-hour morphine consumption by 79% (6.2 vs. 30.2 mg) compared to sham in primary THA under general anesthesia.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This double-blind sham-controlled RCT randomized 40 primary THA patients to ultrasound-guided PENG block with bupivacaine 1 mg/kg (30 mL) versus saline sham under general anesthesia. The PENG group demonstrated 79% lower 24-hour morphine consumption (6.2 vs. 30.2 mg, P<0.001), significantly lower VAS scores at all time points, and prolonged time to first rescue analgesia (16.0 vs. 1.4 hours, P<0.001). Postoperative nausea occurred in 0% vs. 25% of sham patients (P=0.017) with no block-related complications.
Key Limitation
The 24-hour follow-up window captures only the immediate block duration and provides no data on pain control, opioid consumption, or functional outcomes beyond bupivacaine's analgesic window, leaving the block's net clinical impact on recovery undefined.
Original Abstract
BACKGROUND
The pericapsular nerve group (PENG) block has emerged as a promising regional analgesic technique for hip surgery. However, evidence regarding its opioid-sparing efficacy following primary total hip arthroplasty remains limited. This study evaluated the effect of ultrasound-guided PENG block on postoperative opioid consumption, pain scores, and recovery outcomes following primary total hip arthroplasty.
METHODS
In this prospective, randomized, double-blind, sham-controlled trial, 40 patients undergoing elective primary total hip arthroplasty under general anesthesia were randomized to receive either ultrasound-guided PENG block with one mg/kg bupivacaine diluted to 30 mL (n = 20) or a sham procedure with 30 mL saline (n = 20). The primary outcome was cumulative morphine consumption during the first 24 postoperative hours. The secondary outcomes included visual analog scale (VAS) pain scores, time to first rescue analgesia, patient satisfaction, and opioid-related adverse events. Baseline characteristics were comparable between groups.
RESULTS
Cumulative morphine consumption was significantly lower in the PENG group throughout the postoperative period and at 24 hours (6.2 ± 3.3 versus 30.2 ± 5.6 mg, P < 0.001), representing an approximately 79% reduction in opioid requirement. The visual analog scale pain scores were significantly lower at all postoperative assessment points (all P < 0.001). Time to first rescue analgesic requirement was significantly prolonged in the PENG group (16.0 ± 0.0 versus 1.4 ± 0.5 hours, P < 0.001). Patient satisfaction was significantly greater in the PENG group (P < 0.001), while postoperative nausea occurred less frequently (zero versus 25%, P = 0.017). There were no block-related complications observed.
CONCLUSIONS
Ultrasound-guided PENG block provided effective opioid-sparing analgesia following primary total hip arthroplasty, significantly reducing postoperative morphine consumption and pain scores while improving patient satisfaction and reducing postoperative nausea. These findings support the incorporation of PENG block into multimodal analgesic protocols for total hip arthroplasty.